Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 7241Neoplasms 4538Prostatic Neoplasms 3489Colorectal Neoplasms 2939Carcinoma, Non-Small-Cell Lung 2829Lung Neoplasms 2546Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1873Multiple Myeloma 1810Carcinoma, Hepatocellular 1732Neoplasm Metastasis 1585Stomach Neoplasms 1501Lymphoma 1456Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1434Brain Neoplasms 1370Melanoma 1346Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1254Colonic Neoplasms 1204Glioblastoma 1137Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1065Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

lenvatinib 1camrelizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Advanced Triple Negative Breast Cancer × Clear all
NCT06849492 2025-02-27

SHIFT-001

Fudan University

Phase 2 Not yet recruiting
120 enrolled
Breast

Advanced Triple Negative Breast Cancer

NCT05686720 2023-01-17

Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer

First Affiliated Hospital of Shantou University Medical College

Phase EARLY_PHASE1 Unknown
12 enrolled
Breast

Advanced Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡